Literature DB >> 21071881

Clinical features of normal weight Japanese patients with type 2 diabetes who had formerly been obese.

Sanae Tanaka1, Mari Honda, Bin Wu, Tsutomu Kazumi.   

Abstract

AIM: Although the mean body mass index (BMI) of Japanese patients with type 2 diabetes was within the normal range, we have previously shown that approximately half of all patients classified as normal weight had been formerly obese. The present study examined the clinical features of Japanese type 2 diabetic patients who are currently of normal weight but had formerly been obese (NWFO).
METHODS: Body weight history with selfreported body weight was obtainable for 108 of 114 type 2 diabetic outpatients who had been regularly attending our department. Common carotid artery intimamedia thickness (IMT) was also measured.
RESULTS: At the time of the examinations, 5 (5%) and 36 (33%) of 108 type 2 diabetic patients were lean (BMI <18.5 kg/m(2)) and obese (BMI ≥25 kg/m(2)), respectively, whereas normal weight (BMI ≥18.5-<25 kg/m(2)) was found in 67 (62%) patients. Among 108 patients, 67 (62%) were normal weight, of which 32 (48%) were formerly obese (NWFO). NWFO patients with a mean age of 65 years old at the clinic visit had reached their lifetime maximum body weight at age 45 and became diabetic at age 51 years. Obese patients aged 62 years at the clinic visit became diabetic at age 50 and had reached their maximum weight at age 51 years. Diabetes duration was 11 years in patients who had never been obese. Thus, NWFO patients had been exposed to obesity-related metabolic abnormalities and/or hyperglycemia for 20 years on average whereas obese and never obese patients had been exposed for 11-12 years. Although obese patients had higher fasting TG and greater BMI than NWFO, both obese and NWFO patients had similarly lower HDL cholesterol levels than those who had never been obese; however, there was no difference among the 3 groups in diabetic treatment, diabetes duration, HbA1c levels, and prevalence of atherosclerotic risk factors, including smokers, users of statins and antihypertensive drugs. Carotid max IMT was thicker in NWFO type 2 diabetic patients (0.86±0.04 mm) than either obese patients (0.78±0.03 mm, p=0.041) or those who had never been obese (0.78±0.02 mm, p=0.046).
CONCLUSION: This report confirms that approximately half of 108 Japanese type 2 diabetic patients who are currently normal weight were formerly obese and shows that these patients had a thicker carotid IMT than either obese patients or those who had never been obese. Formerly obese diabetic patients who have lost weight and are currently normal weight might have been exposed to long-term obesity-related cardiometabolic abnormalities and/or hyperglycemia, resulting in increased common carotid IMT. We therefore suggest that an improved clinical screening tool would include the assessment of body weight history for all Japanese type 2 diabetic patients at their first clinic visit.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071881     DOI: 10.5551/jat.5926

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  10 in total

1.  Lean NASH: distinctiveness and clinical implication.

Authors:  Kausik Das; Abhijit Chowdhury
Journal:  Hepatol Int       Date:  2013-10-17       Impact factor: 6.047

2.  Lean Fatty Liver Disease: Through Thick and Thin.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-06-18

3.  Inherited β-cell dysfunction in lean individuals with type 2 diabetes.

Authors:  Anne E W Mathews; Clayton E Mathews
Journal:  Diabetes       Date:  2012-07       Impact factor: 9.461

4.  Comparison of Goto-Kakizaki rats and high fat diet-induced obese rats: Are they reliable models to study Type 2 Diabetes mellitus?

Authors:  Wilson Mitsuo Tatagiba Kuwabara; Ana Carolina Panveloski-Costa; Caroline Naomi Fukusawa Yokota; Joice Naiara Bertaglia Pereira; Jorge Mancini Filho; Rosangela Pavan Torres; Sandro Massao Hirabara; Rui Curi; Tatiana Carolina Alba-Loureiro
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

5.  Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes.

Authors:  Kiyohiko Takahashi; Kyu Yong Cho; Akinobu Nakamura; Aika Miya; Arina Miyoshi; Chiho Yamamoto; Hiroshi Nomoto; Hirokatsu Niwa; Kiyohito Takahashi; Naoki Manda; Yoshio Kurihara; Shin Aoki; Yoichi M Ito; Tatsuya Atsumi; Hideaki Miyoshi
Journal:  J Diabetes Investig       Date:  2018-09-26       Impact factor: 4.232

6.  Reduced gluteofemoral (subcutaneous) fat mass in young Japanese women with family history of type 2 diabetes: an exploratory analysis.

Authors:  Mari Honda; Ayaka Tsuboi; Satomi Minato-Inokawa; Mika Takeuchi; Miki Kurata; Bin Wu; Tsutomu Kazumi; Keisuke Fukuo
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

7.  The long-term coronary heart disease risk of previously obese patients with type 2 diabetes mellitus.

Authors:  Ritsuko Yamamoto-Honda; Hideki Ehara; Hiroji Kitazato; Yoshihiko Takahashi; Shoji Kawazu; Yasuo Akanuma; Mitsuhiko Noda
Journal:  BMC Endocr Disord       Date:  2013-10-03       Impact factor: 2.763

8.  FTO Gene Polymorphism Is Associated with Type 2 Diabetes through Its Effect on Increasing the Maximum BMI in Japanese Men.

Authors:  Yutaka Kamura; Minoru Iwata; Shiro Maeda; Satomi Shinmura; Yukiko Koshimizu; Hisae Honoki; Kazuhito Fukuda; Manabu Ishiki; Isao Usui; Yasuo Fukushima; Atsuko Takano; Hiromi Kato; Shihou Murakami; Kiyohiro Higuchi; Chikaaki Kobashi; Kazuyuki Tobe
Journal:  PLoS One       Date:  2016-11-07       Impact factor: 3.240

9.  Decreased arterial distensibility and postmeal hyperinsulinemia in young Japanese women with family history of diabetes.

Authors:  Mika Takeuchi; Bin Wu; Mari Honda; Ayaka Tsuboi; Kaori Kitaoka; Satomi Minato; Miki Kurata; Tsutomu Kazumi; Keisuke Fukuo
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

Review 10.  Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors.

Authors:  Beska Z Witka; Dede J Oktaviani; Marcellino Marcellino; Melisa I Barliana; Rizky Abdulah
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-18       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.